EMEA-000156-PIP01-07-M02

Key facts

Active substance
Antigen of pre-pandemic strain A/Vietnam/1203/2004 propagated in Vero cells
Therapeutic area
Vaccines
Decision number
P/67/2011
PIP number
EMEA-000156-PIP01-07-M02
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Influenza infection caused by an influenza strain contained in the vaccine or related to a strain contained in the vaccine
Route(s) of administration
Intramuscular injection
Contact for public enquiries
Applicant: Baxter Innovations GmbH
E-mail: johannes_braun@baxter.com
Country: Austria
Phone: +43 1201002542
Fax: +43 120100727
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000156-PIP01-07-M02
Compliance opinion date
17/01/2013
Compliance outcome
positive

Decision

How useful was this page?

Add your rating